Breaking News Instant updates and real-time market news.

OMER

Omeros

$24.95

2.3 (10.15%)

10:52
05/15/18
05/15
10:52
05/15/18
10:52

Some investors may be reaching wrong conclusions about Omeros, Feuerstein says

Adam Feuerstein tweeted: "Remarkable how a few carefully crafted sentences in an $OMER press release can cause some investors to jump to conclusions that are quite possibly, even likely, to be totally wrong." Reference Link

OMER Omeros
$24.95

2.3 (10.15%)

03/02/18
NEED
03/02/18
DOWNGRADE
NEED
Hold
Needham downgrades Omeros amid 'plummeting' Omidria sales
Needham analyst Serge Belanger downgraded Omeros to Hold from Buy saying there is no visibility on a near-term resolution to Omidria's reimbursement status or when sales will resume at a "meaningful level." He sees an uncertain future for the drug without reimbursement and notes its sales are "plummeting." It is now unclear if Omeros has the resources to advance OMS721 development programs without Omidria revenue contributing to the funding, Belanger tells investors in a research note. Omeros in midday trading is down 8% to $9.01 following last night's Q4 results.
03/22/18
MAXM
03/22/18
NO CHANGE
Target $25
MAXM
Buy
Omeros short-term reimbursement overhang removal 'great news,' says Maxim
Maxim analyst Jason McCarthy said Omeros resolution of of reimbursement "pass through" status removes an overhang. McCarthy expects Omidria to return to its previous trend of growing sales, and raised his estimates for 2018 to account for the news, while increasing his price target to $25 from $24 and reiterating a Buy rating on Omeros shares
03/23/18
WEDB
03/23/18
DOWNGRADE
Target $19
WEDB
Neutral
Omeros downgraded to Neutral from Outperform at Wedbush
Wedbush analyst Liana Moussatos downgraded Omeros to Neutral and lowered her price target for the shares to $19 from $47. The analyst sees a "lack of clarity for the financial status" with disruption in Omidria sales and the company's inability to fund progress with its top potential value driver OMS721. Even with possible extension of Omidria pass-through reimbursement for two additional years starting in October 2018, sales are unlikely to fund the pipeline in 2018 and 2019, Moussatos tells investors in a research note. Omeros closed yesterday up 35%, or $4.11, to $15.75.
03/23/18
HCWC
03/23/18
NO CHANGE
Target $34
HCWC
Buy
Omeros price target raised to $34 from $30 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Omeros to $34 after Omidria pass-through reimbursement status was extended. The language in the spending bill provides the extension for a period of two years, Selvaraju tells investors in a research note. This is an "unexpected success" for Omeros, and should lead to a "significant rebound" in Omidria sales and resumption of growth in the franchise, Selvaraju writes. He reiterates a Buy rating on Omeros shares.

TODAY'S FREE FLY STORIES

MPSYF

Morphosys AG

$0.00

(0.00%)

09:07
09/19/18
09/19
09:07
09/19/18
09:07
Conference/Events
Morphosys AG has a conference call hosted by JPMorgan »

JPMorgan Analyst Gordon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

EVI

EnviroStar

$42.25

0.05 (0.12%)

09:06
09/19/18
09/19
09:06
09/19/18
09:06
Hot Stocks
EnviroStar to acquire laundry distribution and service business »

EnviroStar announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLRN

Acceleron

$54.03

2.03 (3.90%)

09:05
09/19/18
09/19
09:05
09/19/18
09:05
Conference/Events
Acceleron management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

ABBV

AbbVie

$92.60

-2.77 (-2.90%)

09:05
09/19/18
09/19
09:05
09/19/18
09:05
Recommendations
AbbVie analyst commentary  »

AbbVie's California…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$5.80

0.35 (6.42%)

, HUM

Humana

$335.84

1.93 (0.58%)

09:05
09/19/18
09/19
09:05
09/19/18
09:05
Hot Stocks
Fitbit, Humana expand strategic partnership »

Fitbit (FIT) and Humana…

FIT

Fitbit

$5.80

0.35 (6.42%)

HUM

Humana

$335.84

1.93 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

09:05
09/19/18
09/19
09:05
09/19/18
09:05
General news
U.S. equities are trading flat to lower »

U.S. equities are trading…

VIRT

Virtu Financial

$22.05

0.2 (0.92%)

09:04
09/19/18
09/19
09:04
09/19/18
09:04
Initiation
Virtu Financial initiated  »

Virtu Financial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$27.59

0.17 (0.62%)

, MGP

MGM Growth

$30.03

-0.01 (-0.03%)

09:04
09/19/18
09/19
09:04
09/19/18
09:04
Hot Stocks
MGM Resorts, MGM Growth sign agreement for Northfield,Ohio Hard Rock Rocksino »

MGM Resorts (MGM) and MGM…

MGM

MGM Resorts

$27.59

0.17 (0.62%)

MGP

MGM Growth

$30.03

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

DISCA

Discovery

$31.58

-0.43 (-1.34%)

09:03
09/19/18
09/19
09:03
09/19/18
09:03
Recommendations
Discovery analyst commentary  »

Discovery price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRY

Tilray

$154.99

34.79 (28.94%)

, MOC

Command Security

$1.90

0.08 (4.40%)

09:02
09/19/18
09/19
09:02
09/19/18
09:02
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Tilray (TLRY), up…

TLRY

Tilray

$154.99

34.79 (28.94%)

MOC

Command Security

$1.90

0.08 (4.40%)

SPWR

SunPower

$7.55

0.97 (14.74%)

JNPR

Juniper

$28.60

0.6 (2.14%)

ARPO

Aerpio Pharmaceuticals

$3.77

0.155 (4.29%)

MGM

MGM Resorts

$27.59

0.17 (0.62%)

LYB

LyondellBasell

$102.16

-1.3 (-1.26%)

GTHX

G1 Therapeutics

$62.94

-3.41 (-5.14%)

RFP

Resolute Forest

$14.65

0.125 (0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 11

    Oct

  • 16

    Oct

  • 27

    Nov

  • 19

    Sep

WP

Worldpay

$98.50

0.7 (0.72%)

09:01
09/19/18
09/19
09:01
09/19/18
09:01
Hot Stocks
Worldpay co-CEO Philip Jansen to step down at end of 2018 »

Worldpay announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

NFLX

Netflix

$367.85

17.61 (5.03%)

09:00
09/19/18
09/19
09:00
09/19/18
09:00
Technical Analysis
Technical Take: Netflix extends its run, analyst action »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

08:59
09/19/18
09/19
08:59
09/19/18
08:59
Hot Stocks
Breaking Hot Stocks news story  »

CBX trading halted, news…

TLRY

Tilray

$154.99

34.79 (28.94%)

08:55
09/19/18
09/19
08:55
09/19/18
08:55
Hot Stocks
Tilray shares go mad after CEO appears on CNBC's Mad Money »

Shares of Tilray (TLRY),…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$31.93

-0.51 (-1.57%)

, FTV

Fortive

$87.39

0.25 (0.29%)

08:55
09/19/18
09/19
08:55
09/19/18
08:55
Options
Notable open interest changes for September 19th »

Tuesday's total…

AMD

AMD

$31.93

-0.51 (-1.57%)

FTV

Fortive

$87.39

0.25 (0.29%)

BAC

Bank of America

$30.22

-0.05 (-0.17%)

PBR

Petrobras

$11.23

0.305 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 25

    Sep

  • 27

    Sep

AZO

AutoZone

$732.74

-14.79 (-1.98%)

, AAP

Advance Auto Parts

$167.64

4.25 (2.60%)

08:54
09/19/18
09/19
08:54
09/19/18
08:54
Recommendations
AutoZone, Advance Auto Parts, O'Reilly Automotive analyst commentary  »

AutoZone price target…

AZO

AutoZone

$732.74

-14.79 (-1.98%)

AAP

Advance Auto Parts

$167.64

4.25 (2.60%)

ORLY

O'Reilly Automotive

$340.65

3.98 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

TLRY

Tilray

$154.99

34.79 (28.94%)

08:53
09/19/18
09/19
08:53
09/19/18
08:53
Hot Stocks
Citron says still short Tilray, recent rally 'beyond comprehension' »

Short-seller Citron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROW

T. Rowe Price

$109.29

0.3 (0.28%)

08:53
09/19/18
09/19
08:53
09/19/18
08:53
Conference/Events
T. Rowe Price management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

08:53
09/19/18
09/19
08:53
09/19/18
08:53
Conference/Events
Roth Capital to hold a conference »

4th Annual Datacenter…

08:50
09/19/18
09/19
08:50
09/19/18
08:50
Conference/Events
Canaccord to hold a conference »

Artificial Intelligence…

08:50
09/19/18
09/19
08:50
09/19/18
08:50
General news
U.S. Q2 current account deficit narrowed to -$101.5 B »

U.S. Q2 current account…

08:50
09/19/18
09/19
08:50
09/19/18
08:50
General news
Treasury Action: yields drifted below highs »

Treasury Action: yields…

HEAR

Turtle Beach

$17.75

-1.55 (-8.03%)

08:49
09/19/18
09/19
08:49
09/19/18
08:49
Recommendations
Turtle Beach analyst commentary  »

Turtle Beach 45% pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEA

Lear

$154.96

-2.2 (-1.40%)

08:47
09/19/18
09/19
08:47
09/19/18
08:47
Recommendations
Lear analyst commentary  »

Lear price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

TNDM

TNDM

08:47
09/19/18
09/19
08:47
09/19/18
08:47
Conference/Events
Tandem Diabetes management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.